about
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt ...
Read More
1.58
-0.10
(-5.95%)
706.4K
XNAS Volume
XNAS 28 Aug, 2025 4:19 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
IO Biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..